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Meinem Vater  
 
„Leben ist Brückenschlagen über Ströme, die vergehen“ 
-Konstantin Wecker-
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1. Summary 
The organs of the excretory system of mouse and men, the kidney, ureter, bladder 
and urethra are needed for blood filtration, urine production, storage and release. 
Defects in the development of the ureter, which transports the urine from the kidney 
to the bladder by peristaltic contractions, can lead to impaired urine transport due to 
physical or functional obstruction. The consequences are urine accumulation and 
increasing hydrostatic pressure, which cause damage to the ureter (hydroureter) and 
kidney (hydronephrosis). These kinds of malformations belong to a spectrum of 
congenital anomalies of the kidney and urinary tract (CAKUT), which are the most 
common cause of chronic kidney disease in children.  
Loss of the T-box transcription factor Tbx18 results in a hydroureter and 
hydronephrosis phenotype in mice. The defects are caused by failing ureteric smooth 
muscle development. At E11.5, Tbx18 is expressed in a mesenchymal precursor 
population of the metanephrogenic field, where ureter and kidney development is 
initiated. This mesenchymal precursor population is associated with the newly formed 
ureteric epithelium and borders on the mesenchymal precursors of the newly formed 
kidney primordium. During further ureter development Tbx18 expression is 
maintained in the undifferentiated coat of mesenchyme along the ureter. After the 
examination of the Tbx18-loss of function phenotype, it remained unclear, if Tbx18 is 
involved in the early specification of ureteric smooth muscle precursors or in the later 
regulation of smooth muscle development and differentiation.  
In this thesis the functional analysis of Tbx18 in ureter development has been 
followed-up in three different in vivo approaches. The first approach addressed the 
early establishment of the Tbx18+ precursor lineage and its later fate. The expression 
of Tbx18 and other known markers of mesenchymal compartments of the urogenital 
precursor ridge was analyzed. This analysis revealed that Tbx18 expression is 
initiated as early as day 9.5 of embryonic development (E9.5) in the cranial part of 
the urogenital ridge (UGR), the gonadal ridge mesenchyme and its coelomic surface 
epithelium. Further caudally, in the metanephrogenic field, Tbx18 became detectable 
between E10.0 and E10.5, with the outgrowth of the ureter from the nephric duct. At 
no time point, there was an overlap between the strand of nephrogenic mesenchyme, 
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which gives rise to the nephric structures of the urogenital ridge, and the Tbx18+ 
population. The Foxd1+ renal stroma precursor population, and the mesenchyme 
along the ureter, which maintained Tbx18 expression were established as two 
separate lineages at E11.5.  
Fate mapping of the Tbx18+ lineage in the organs of the urogenital system proved 
that the smooth muscle layer and all connective tissue layers of the ureter wall are 
derived from the Tbx18+ precursor population. Tbx18-derived cells were also found to 
invade the kidney and contribute to the renal stroma and to most other organs of the 
developing urogenital system. In the Tbx18-loss-of-function mutant the distribution of 
Tbx18-derived cells shifted from the ureteric smooth muscle coat to the stroma 
surrounding the renal pelvis. No Tbx18-derived smooth muscle layer was detectable. 
Hence Tbx18 is needed in the cells derived from the common stroma and ureteric 
mesenchyme precursor population to impose a ureteric instead of the default stromal 
fate.  
In a second approach we analyzed the consequences of temporal and spatial 
misexpression of Tbx18 or a transcription activating Tbx18VP16-allele in different 
mesenchymal domains of the urogenital ridge. Misexpression of Tbx18 throughout 
the lower trunk mesenchyme, including the complete metanephrogenic field, revealed 
that Tbx18 is sufficient to repress the development of nephrogenic mesenchyme, 
resulting in kidney and ureter agenesis. The examination of the Tbx18-loss-of-
function mutant at early stages showed, that it is also needed to repress the early 
metanephric mesenchyme in the ureteric mesenchyme precursor population. Eya1 
was identified as a possible direct target gene of Tbx18 in this process. In vivo 
analysis of two conditional Eya1-misexpression mutants revealed, that deregulation 
of Eya1, after the loss of Tbx18, might contribute to the Tbx18-loss of function 
phenotype.  
Maintained expression of Tbx18 throughout the ureteric mesenchyme and in Tbx18-
derived renal stroma cells resulted in an expansion of the ureteric smooth muscle 
layer towards the epithelium at the expense of the lamina propria connective tissue 
layer of the ureter wall. The fact that the expansion of smooth muscle differentiation 
occurred only in the direction towards the epithelium indicates that another signal is 
needed for this ectopic smooth muscle differentiation. In the renal stroma we 
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detected a less even distribution of the Tbx18 misexpressing cells and an 
accumulation of affected cells in the cortex, close to the ureter entry site. These 
results indicate that Tbx18 can activate ectopic smooth muscle differentiation in a 
subset of ureteric mesenchyme cells and that it might regulate cell adhesion or 
motility. Expression of the Tbx18VP16-allele in the ureteric mesenchyme and Tbx18-
derived stroma prevented smooth muscle development cell autonomously. From this 
finding, it can be concluded, that Tbx18 is needed as a repressing transcription factor 
to allow ureteric development. 
In a third approach, canonical Wnt-signaling between the ureteric epithelium and the 
Tbx18-derived ureteric mesenchyme and its significance for ureteric smooth muscle 
development were analyzed. This analysis revealed that canonical Wnt-signals are 
needed in the mesenchyme to suppress adventitial fibroblast differentiation and allow 
smooth muscle development in the inner layer of mesenchymal cells. This analysis 
also revealed new findings about the connection between the regulation and function 
of Tbx18 and canonical Wnt-signaling in the ureteric mesenchyme. Mouse mutants 
showing misexpression of Tbx18 throughout the ureteric mesenchyme in a canonical 
Wnt-signaling-loss-of-function background were analyzed. The results of this 
analysis, taken together with the results from the Tbx18-gain and loss-of-function 
mutant analysis, indicate that Tbx18 expression and the perception of canonical Wnt-
signals by the ureteric mesenchyme depend on each other. Furthermore, Tbx18 and 
Wnt-signaling are needed in combination for ureteric smooth muscle development. 
Key words: Tbx18; ureter; smooth muscle  
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2. Zusammenfassung  
 
Das Ausscheidungssystem von Maus und Mensch besteht aus Nieren, Harnleitern, 
der Blase und der Harnröhre. Diese Organe sind für die Filtration des Blutes, die 
Produktion und Sammlung von Urin und seinen Transport aus dem Körper 
verantwortlich. Der Harnleiter übernimmt hierbei den aktiven Transport des Urins, 
indem er ihn durch peristaltische Bewegungen von der Niere zur Blase befördert. 
Defekte in der Harnleiterentwicklung können den Harnabfluss stören, wenn sie zu 
physikalischen Blockaden im Transportweg führen oder die peristaltischen 
Bewegungen der Harnleiterwand beeinträchtigen. Hierdurch kann es zur Aufstauung 
des Urins und somit zu einem steigenden hydrostatischen Druck in Harnleiter und 
Niere kommen, der beide Organe schädigt. Die Folgen sind die Bildung von sog. 
Hydroureteren (stark dilatierter Harnleiter), häufig gefolgt von Hydronephrose 
(Erweiterung des Nierenbeckens und des Nierenholsystems, oft mit Schädigung des 
Nierengewebes). Dieses Krankheitsbild gehört zu einem Spektrum von angeborenen 
Fehlbildungen der Niere und ableitenden Harnwege (CAKUT), die die häufigste 
Ursache für chronisches Nierenversagen bei Kindern darstellen.  
Der Verlust des T-box Transkriptionsfaktors Tbx18 führt in der Maus, in Folge einer 
fehlenden Entwicklung der glatten Muskulatur des Harnleiters, zur Ausbildung eines 
Hydroureter- und Hydronephrosephänotyps. Die Organanlagen von Niere und 
Harnleiter entwickeln sich im sog. metanephrogenen Feld. Tbx18 wird in einer 
streifenförmigen, mesenchymalen Zellpopulation des metanephrogenen Feldes, 
exprimiert, die das Harnleiterepithel umhüllt. Die Tbx18+ Population grenzt zu diesem 
frühen Zeitpunkt an die mesenchymale Voräuferpopulation der sich entwickelnden 
Niere. Tbx18-Expression wird von nun an im undifferenzierten Mesenchym des 
Harnleiters aufrechterhalten und mit einsetzender Differenzierung der glatten 
Muskulatur runterreguliert. Nach der Untersuchung des Tbx18-Verlust-Phänotyps 
war es unklar, ob die Funktion von Tbx18 in der frühen Spezifizierung der 
Harnleitermuskulatur-Vorläuferzellen oder in der späteren Regulation ihrer 
Entwicklung und Differenzierung liegt. 
Im Zuge meiner Doktorarbeit wurde die Funktion von Tbx18 während der 
Harnleiterentwicklung weiter untersucht. Die Arbeiten hierzu können drei 
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verschiedenen Ansätzen zugeordnet werden. Im erste Ansatz wurde die frühe 
Tbx18+-Vorläuferpopulation in der Urogenitalleiste und das Schicksal der von ihr 
abgeleiteten Zellen genauer charakterisiert. Zu diesem Zweck wurde die frühe 
Expression von Tbx18 und anderer Markergene beschriebener Zellpopulationen der 
Urogenitalleiste untersucht. Es zeigte sich, dass Tbx18 am Tag 9.5 der 
Embryonalentwicklung (E9.5) im cranialen Bereich der Urogenitalleiste, im 
Oberflächenepithel der Genitalleiste und dem darunterliegenden Mesenchym 
exprimiert ist. Im weiter caudal gelegenen metanephrogenen Feld ist Tbx18 bereits 
zwischen E10.0 und E10.5 mit dem Auswachsen des Harnleiters exprimiert. Von 
Anfang an waren die Tbx18+ Population und das nephrogene Mesenchym, das alle 
nephrischen Strukturen der Urogenitalleiste bildet, klar voneinander abgegrenzt. Die 
Foxd1+ Vorläuferpopulation des renalen Stromas und das Tbx18 exprimierende 
Uretermesenchym unterschieden sich molekular ab E11.5 voneinander. Eine 
Schicksalskartierung in den Organen des Urogenitalsystems bewies, dass die glatte 
Muskulatur und alle Bindegewebeschichten der Harnleiterwand aus Tbx18-
abgeleiteten Zellen entstehen. Auch im Stroma der Niere und in anderen Organen 
des Urogenitalsystems wurden Tbx18-abgeleitete Zellen gefunden. In der Tbx18-
Verlustmutante stellten wir eine Umverteilung der Harnleitermesenchymzellen ins 
Stroma, das das Nierenbecken umgibt, fest. Eine Tbx18-abgeleitete glatte 
Muskelschicht des Harnleiters war nicht nachweisbar. Daraus lässt sich schließen, 
dass Tbx18 benötigt wird, um in einem Teil der Uretermesenchym- und Stroma-
Vorläuferpopulation das Uretermesenchym-Schicksal zu vermitteln im Gegensatz 
zum Stroma-Schicksal der Zellen, die die Tbx18-Expression verlieren.  
In einem zweiten Ansatz untersuchten wir die Auswirkungen von zeitlicher und 
räumlicher Misexpression von Tbx18 oder einer Transkription-aktivierenden 
Tbx18VP16-Variante in verschiedenen mesenchymalen Populationen der 
Urogenitalleiste. Misexpression von Tbx18 im Mesenchym des gesamten caudalen 
Rumpfbereichs, inklusive des gesamten metanephrogenen Feldes, zeigte, dass 
Tbx18 die Entwicklung von nephrogenem Mesenchym verhindert, wodurch die 
Entwicklung von Niere und Harnleiter ausbleibt. Die Untersuchung der Tbx18-
Verlustmutante zeigte, dass Tbx18 nicht nur dieses Potenzial hat, sondern auch 
benötigt wird um das frühe Expressionsprogramm des Nierenmesenchyms in der 
benachbarten Harnleitermesenchym-Population zu unterdrücken. Eya1 wurde als ein 
mögliches direktes Zielgen von Tbx18 in diesem Prozess identifiziert. Die in vivo-
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Analyse zweier konditioneller Eya1-Missexpressionsmutanten wies darauf hin, dass 
die Fehlregulation von Eya1 in der Tbx18-Verlustmutante zur Entstehung des 
Phänotyps beiträgt.  
Misexpression im gesamten Harnleitermesenchym und in den Tbx18-abgeleiteten 
Zellen des Nierenstromas führte zu einem Verlust der Lamina propria, der inneren 
Bindegewebsschicht der Harnleiterwand. Das an das Ureterepithel angrenzende 
Gewebe zeigte nun ektopische Entwicklung von glatter Muskulatur. Diese Ergebnisse 
weisen darauf hin, dass Tbx18 eine Funktion in die Spezifizierung oder 
Differenzierung der Harnleitermuskulatur hat, vermutlich gemeinsam mit anderen 
vom Harnleiterepithel ausgehenden Signalen. Im Nierenstroma führte die 
Missexpression zu einer veränderten Verteilung der betroffenen Zellen, die eine 
Regulation von Zelladhäsion durch Tbx18 hinweisen könnten. Expression eines 
Tbx18-VP16-Allels im Harnleitermesenchym und in den Tbx18-abgeleiteten Zellen im 
Nierenstroma verhinderte die Differenzierung von glatter Muskulatur zellautonom, 
was darauf hinweist, dass Tbx18 in der Entwicklung der Harnleitermuskulatur als 
reprimierender Transkriptionsfaktor gebraucht wird.  
In einem dritten Ansatz wurde der Austausch von kanonischen Wnt-Signalen 
zwischen Harnleiterepithel und –mesenchym und die Bedeutung dieses Signalweges 
für die Entwicklung der glatten Muskulatur des Harnleiters untersucht. Diese Analyse 
zeigte, dass kanonische Wnt-Signale im Mesenchym gebraucht werden, um die 
Entwicklung von Lamina propria-Fibroblasten im inneren Harnleitermesenchym zu 
verhindern und stattdessen die Entwicklung der glatten Muskulatur zu ermöglichen. 
Diese Untersuchung  brachte auch neue Erkenntnisse über den Zusammenhang 
zwischen Tbx18-Expression und –Funktion und dem kanonischen Wnt-Signalweg im 
Harnleitermesenchym. Mausmutanten, die Misexpression von Tbx18 im gesamten 
Harnleitermesenchym bei einem gleichzeitigen genetischen Verlust des kanonischen 
Wnt-Signalweges zeigten, wurden analysiert. Die Ergebnisse wiesen, zusammen mit 
den Ergebnissen der Tbx18-Verlustmutantenanalyse und der Analyse der Tbx18-
Misexpressionsmutanten darauf hin, dass Tbx18-Expression und das Empfangen 
von kanonischen Wnt-Signalen im Harnleitermesenchym voneinander abhängen. 
Tbx18 und kanonische Wnt-Signale werden gemeinsam für die Entwicklung der 
glatten Muskulatur am Harnleiter benötigt. 
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Schlagwörter: Tbx18; Ureterentwicklung; Glatte Muskulatur 
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ACTA 
 
α-smooth muscle actin 
BOR branchio-oto-renal-syndrome 
BrdU Bromodeoxyuridine 
CAKUT Congenital Anomalies of the Kidney and the Urinary Tract 
CDS Collecting duct system  
CM Cap mesenchyme 
Cre Cre recombinase 
Ctnnb1 β-Catenin 
DAB 3, 3 –diaminobenzidine 
DAPI 4',6-diamidino-2-phenylindole 
DMSO Dimethylsulfoxid 
DNA Deoxyribonucleic acid 
E Day of embryonic development 
EGFP Enhanced GFP 
Fig Figure 
FITC Fluorescein 
GFP Green fluorescent protein 
H&E  Hematoxylin & Eosin labeling 
Hprt Hypoxanthine phosphoribosyltransferase 
IgG Immunoglobulin G 
IM Intermediate mesoderm  
IRES Internal ribosome entry site 
KO Knock out 
LacZ β-Galactosidase 
Mes Mesonephric tubules 
MET Mesenchymal to epithelial transition 
MM Metanephric mesenchyme 
ND Nephric duct / Wolffian duct  
NM Nephrogenic mesenchyme 
ORF Open reading frame 
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PBS Phosphate-buffered saline 
PBST 0,05% Tween 20 in PBS 
PCR Polymerase chain reaction 
PFA Paraformaldehyde 
PGC Primordial germ cell 
RNA Ribonucleic acid 
SM smooth muscle 
SMCs Smooth muscle cells 
TSA Tetramethylrhodamine amplification  
TUNEL TdT-mediated dUTP-biotin nicked end  
UB Ureteric bud 
UE Ureteric epithelium 
UGR Urogenital ridge  
UGS Urogenital organ system  
UM Ureteric mesenchyme 
UT Ureteric tip 
γm Micrometer 
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5. Erklärung zur kumulativen Dissertation  
von Eva Christina Bettenhausen (geboren am 14.10.1984 in Kassel) 
Diese kumulative Dissertation basiert auf folgenden Artikeln und zwei bisher 
unveröffentlichten Manuskripten: 
Artikel 1: 
Bohnenpoll T (1)  and Bettenhausen E (2), Weiss AC, Foik AB, Trowe MO, Blank P, 
Airik R and Kispert A.  
„Tbx18 expression demarcates multipotent precursor populations in the 
developing urogenital system but is exclusively required within the ureteric 
mesenchymal lineage to suppress a renal stroma fate“ 
Developmental Biology 2013, August 380(1), 25-36 
Autor (1) und (2) teilen sich die Erstautorenschaft für diese Publikation  
Ich habe für Artikel 1 die Abbildungen Abb. 2B, Abb. 3 (außer B und C), Abb. 4 A, 
B, C+E, Abb. S2, S3 A-I, S4, und S5 erstellt und die zu Grunde liegenden Daten 
generiert. Diese Abbildungen enthalten die Ergebnisse der Zellschicksalsanalyse der 
Tbx18-abgeleiteten Zellen in den Organen des Urogenitalsystems, die 
Quantifizierung der Tbx18-abgeleiteten Zellen, die zum renalen Stroma beitragen, die 
Dokumentation der Einwanderung dieser Zellen in vivo, sowie die vergleichende 
Schicksalskartierung und Quantifizierung der Tbx18-abgeleiteten Zellen in der 
Tbx18-Verlust-Mutante und der heterozygoten Kontrolle. Des Weiteren habe ich zum 
inhaltlichen Konzept des Manuskripts beigetragen. Tobias Bohnenpoll hat zu diesem 
Manuskript die frühe vergleichende Expressionsanalyse in Abb. 1, die Ex vivo-
Zellschicksalsanalyse von Tbx18-abgeleiteten Zellen in explantierten Nieren-
Organanlagen in Abb. 4 F, die Abstammungs- und Apoptose-Analyse in 
explantierten Nieren-Organanlagen in Abb. 5 A-C, die Analyse der Tbx18-Regulation 
im Uretermesenchym in Abb. 6 A+C sowie die frühe Zellschicksalsanalyse in Abb. 
S1 und die ex vivo Zellschicksalsanalyse des Tbx18+ Uretermesenchyms in Abb. S6 
beigetragen. Anna-Carina Weiss hat die Vergleichende Expressionsanalyse in Abb. 
2A, die Apoptose-Analyse mittels Terminal deoxynucleotidyl transferase dUTP nick 
and labeling (TUNEL) -Untersuchung in Abb. 5D, die Expressionsanalyse im 
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Uretermesenchym in Abb. 6B und die Expressionsanalyse in der Nebenniere in Abb. 
S3 J-P durchgeführt. Mark-Oliver Trowe hat die adulten Urogenitalsysteme in Abb. 3 
B und C präpariert und dokumentiert. Rannar  Airik hat Vorarbeiten für die Erstellung 
von Abb. 1 geleistet. Mark-Oliver Trowe, Patrick Blank und Anna-Barbara Foik haben 
technische Hilfestellungen geleistet. Andreas Kispert hat das Manuskript geplant und 
verfasst, war an der Züchtung der verwendeten Mausstämme beteiligt, leistete 
technische Hilfestellungen und hat das Projekt finanziert. 
 
Artikel 2: 
Trowe MO and Airik R, Weiss AC, Farin HF, Foik AB, Bettenhausen E, Schuster-
Gossler K, Taketo MM and Kispert A.  
„Canonical Wnt signaling regulates smooth muscle precursor development in 
the mouse ureter“ 
Development 2012, September 139(17), 3099-108. 
Zu Artikel 2 habe ich die experimentelle Arbeit zur Generierung der Abb. S1 B-E 
beigetragen. Mark-Oliver Trowe und Rannar Airik haben den Großteil der Arbeiten an 
diesem Artikel durchgeführt. Anna-Barbara Foik hat technische Hilfestellung 
geleistet. Henner Farin und Karin Schuster-Gossler sowie Makoto Mark Taketo 
haben Mauslinien generiert oder zur Verfügung gestellt. Mark-Oliver Trowe und 
Andreas Kispert haben das Manuskript geschrieben und Andreas Kispert hat das 
Projekt finanziert. 
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und überarbeitet. Die Expressionsanalyse im Uretermesenchym bei E12.5 in Abb. 
S5 wurde von Anna-Carina Weiss durchgeführt. Henner Farin hat den HprtTbx18-
Mausstamm generiert. Mark-Oliver Trowe, Anna-Barbara Foik und Carsten Rudat 
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haben technische Hilfestellungen geleistet. Die Daten auf denen Abb. 1 basiert, und 
Vorarbeiten zur Abb. 2  wurden im Zuge meiner Masterarbeit generiert, die ich 
ebenfalls im Institut für Molekularbiologie, in der Arbeitsgruppe von Andreas Kispert 
angefertigt habe („Missexpressionsexperimente in vivo zur Analyse der Funktion des 
T-box-Transkriptionsfaktors Tbx18 in der Entwicklung des Uretermesenchyms“, Eva 
Bettenhausen, 2010). Die HprtEya1-Mauslinie wurde, im Zuge dieser Arbeit, von mir 
nach einem etablierten Verfahren generiert. Die anderen verwendeten Mausstämme 
waren im Labor vorhanden. Andreas Kispert verfasste das Manuskript, war beteiligt 
an der Zucht der verwendeten Mausstämme, leistete technische Hilfestellung und 
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Andreas Kispert editierte Teile des Manuskripts und finanzierte das Projekt.  
 
Introduction 
 
1 
 
6. Introduction 
6.1. Anatomy and function of the murine urogenital organ system 
The urogenital system (UGS) of the mouse and of all other amniotes (mammals, 
birds and reptiles) can be divided into two units, which are functionally and 
anatomically tightly connected (Fig.1). One of these units is the reproductive system, 
which consists of the gonads and the sex ducts. The second unit is composed of the 
excretory organs. In the mouse these are the paired kidneys, the ureters, the bladder 
and the urethra. Urine produced by the kidneys is drained to the bladder by the 
ureters, two tube shaped organs consisting of a multilayered epithelium, clad in 
layers of connective tissue and smooth muscle tissue 1. The bladder stores the urine 
until micturition, when it is released from the body by the urethra. The three main 
functions of the excretory organ system are the removal of waste products of protein 
and nucleotide metabolism and other potentially harmful substances from the blood, 
the resorption of beneficial substances like glucose from the primary urine, and the 
regulation of the blood pressure by balancing the amount of water and salt retained 
in the body 2. The site of blood filtration and urine production in the kidney is the 
nephron (Fig.1). The adult mouse kidney harbors about 11.000 nephrons 3. Blood 
filtration takes place inside the renal corpuscle. A renal corpuscle consists of a tuft of 
capillaries, the glomerulus, enclosed by Bowman`s capsule, a cup-like epithelial 
structure. Bowman`s capsule is the first epithelial segment of the nephron. It is 
followed by a long, segmented epithelial tube. While the primary filtrate, generated in 
the glomerulus, passes through this tube, specific molecules are resorbed from it into 
the tightly associated blood vessels. All nephrons finally drain the urine they produce 
into the collecting duct system (CDS), which can resorb more water if necessary. The 
CDS opens into the pelvis at the tip of the renal papilla. Unlike the human kidney, the 
murine kidney possesses only a single, central papilla. In the pelvis urine 
accumulates until a peristaltic contraction, which is propagated along the ureteric 
smooth muscle layer, actively pumps the fluid down to the bladder. To fulfil this 
function the mature ureteric wall is equipped with a coat of smooth muscle tissue and 
its inner surface is lined by a specialized urothelium, which can withstand the high 
osmolarity of the urine 1. The distal end of the ureter opens into the urinary bladder 
via the valve-like ureteral orifice, which prevents reflux of the urine up to the kidney. 
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The mature bladder wall consists of a thick layer of randomly oriented smooth muscle 
fibers and its inner lumen is also lined by a multilayered urothelium 4,5. This tissue 
architecture allows the collection and storage of urine until it is released from the 
body through the urethra. During embryonic development the organs of the excretory 
system are established in a stepwise process. This process involves the early 
specification of precursor tissues and later signal exchange between them to allow 
the development of organ primordia, growth and differentiation. 
 
 
Fig.1: Anatomy of the adult murine urogenital organ system 
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6.2. Development of the mouse UGS and its molecular regulation 
Two progenitor tissues contribute to the developing organs of the UGS, these are the 
intermediate mesoderm (IM) and the endoderm. An endodermal infolding, the cloaca, 
gives rise to the bladder, and urethra as well as to parts of the female vagina 6. The 
intermediate mesoderm (IM) is the main progenitor tissue of the kidneys and ureters. 
The IM also gives rise to the gonads of both sexes, testes and ovaries and to the vas 
deferens, the male sex ducts 7–9.  
The IM becomes first detectable after gastrulation between the paraxial mesoderm 
and the lateral plate mesoderm (Fig. 2). It gives rise to the urogenital ridge (UGR), 
paired strands of mesenchymal tissue, which stretch along the dorsal body wall from 
the heart region to the tailbud region of the embryo on either side of the gut 
mesentery 3. Their ventral side is covered by the coelomic epithelium. In amniotes 
three generations of nephric organs, the pronephros, the mesonephros and the 
metanephros, are established within the UGR consecutively and in a cranial to 
caudal progression 3. While the first two generations degenerate nearly completely 
before birth and are never functional as excretory organs, the metanephros, as the 
last and most caudally established kidney generation persists in the mouse to 
become the mature kidney. 
 
Fig. 2: The intermediate mesoderm (IM) at E8.5 The figure is based on information from EMAP 
eMouse Atlas Project (http://www.emouseatlas.org)
10
. 
In the further course of development progenitor populations or lineages are 
established within the UGR by the expression of specific sets of transcription factors 
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(Fig. 3). These precursor populations will then establish the organ primordia. Initially, 
at E7.5, the complete UGR is marked by expression of the zinc finger transcription 
factor  Osr1 7,11. The paired-box transcription factors Pax2 and Pax8 are the first two 
markers, which are restricted to the nephrogenic lineage, a mesenchymal population 
within the UGR, which is capable to give rise to epithelial nephric structures by 
mesenchymal to epithelial transition (MET) when induced by external signals  12. 
MET leads to the formation of the pronephric tubules at about E8.0. These tubules 
fuse to initiate the formation of the Wolffian or nephric duct (ND) at the level of the 
forelimb buds 3,13. While the pronephros exists only transiently in the mouse, the ND, 
which is marked by expression of Lhx1, Ret, Pax2, Pax8 and Wnt9b 14–17 grows out 
in the caudal direction until it reaches the cloaca and connects with it between E9.5 
and E10.0 18. With the formation of the ND the epithelial precursor structure, which 
induces the formation of the two following generations of nephric structures in the 
surrounding nephrogenic mesenchyme (NM) is established 15,19.  
The strand of NM runs along the UGR on the dorsal side of the ND. It is capable to 
respond to the inductive Wnt9b signals coming from the ND epithelium by MET. The 
NM lineage is also marked by expression of a specific combination of transcriptional 
regulators. Osr1 and Wt1, which earlier showed a broader expression domain within 
the IM, are later restricted to the NM, whereas Sall1 Six1, Six2 and Eya1 are specific 
markers of the NM lineage 20–22. Expression of Pax2 and Pax8 is maintained in the 
epithelium of the ND as well as in the NM. The mesonephros, the second transitory 
generation of kidneys in the embryo, becomes detectable at about E9.0 at a level 
between the fore- and the hindlimb bud 15,19. It consists of several NM-derived 
epithelial tubules. In female mammals the mesonephric second kidney generation 
degenerates completely, while some of the cranial mesonephric tubules persist in the 
male to establish the connection between the vas deferens and the testis. The 
gonads themselves are derived from the gonadal ridge, a precursor field within the 
UGR next to the mesonephros, which becomes detectable shortly before E10.5 by a 
thickening of the coelomic epithelium 23. The early, bi-potential gonad contains 
primordial germ cells as well as somatic cells, which provide a kind of matrix to 
support the germ cells 24. In the testis of male embryos the somatic portion of the 
gonad primordium gives rise to the following cell types of the testis: Sertoli cells of the 
epithelial testis cords, in which the germ cells are embedded, peritubular myoid cells, 
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which surround the testis cords, fetal Leydig cells, which fill the interstitium between 
the chords, and endothelial cells. The germ cells migrate into the organ primordium 
between E10.5 and E11.5, coming from the base of the allantois 23–25.  
Finally, the development of the third, persistent kidney generation, the metanephros, 
is initiated. At E10.0 the metanephric blastema or metanephric mesenchyme (MM) 
becomes morphologically and molecularly distinguishable. It is located at the level of 
the hindlimb bud in the so-called metanephrogenic field at the caudal end of the 
strand of NM. The MM expresses a unique combination of transcription factors 
specifying it as the main mesenchymal precursor population of the developing 
kidney. Osr1, Wt1, Sall1, Six1, Eya1 and Pax2 were earlier expressed throughout the 
strand of NM and become restricted to the MM with the onset of metanephric kidney 
development. The three functionally redundant paralogous Homeobox (Hox)-genes 
Hoxa11, Hoxc11 and Hoxd11 are expressed only in the most caudal part of the 
strand of NM and thereby determine the position of the MM along the cranio-caudal 
body axis 26. All of these factors are required for normal metanephric development 
and the loss of either of them results in renal agenesis in mouse mutants. But only 
the knock out mutants of Osr1 and Eya1, which is thought to act downstream of 
Osr1, show a failing initial establishment of the MM 11,20. This indicates their function 
in the early specification of the MM or the NM in general. In contrast, knock-out 
mutants of Six1, Wt1, Pax2, Sall1 or the three Hox11 paralogs initially establish the 
MM but lose it subsequently 22,27–30. In the MM Eya1 interacts with Pax2, Six1 and the 
Hox11 paralogous factors in a transcriptional complex to activate the expression of 
the MM specific genes Six2 and Gdnf 30,31. Spatio-temporal restriction of Gdnf 
expression is a prerequisite for metanephric kidney development, as GDNF, secreted 
by MM cells, induces the outgrowth of the epithelial ureteric bud (UB) from the ND. 
Ureteric budding is induced by GDNF signaling via the receptor tyrosine kinase RET 
and the GPI-linked cell surface co-receptor Gfrα1, expressed in the ND epithelium 32. 
At E10.5 the UB enters the MM. This invasion is needed for further metanephric 
development, as the UB induces the mesenchyme to survive and proliferate. Without 
Gdnf expression ureteric outgrowth and invasion of the MM does not occur, which 
explains the subsequent loss of the MM in Pax2, Hox11 and Six1-mutants. 
Between E10.5 and E11.5 the mesenchymal precursor population, which will give 
rise to all nephrons of the developing kidney, the so called cap mesenchyme (CM), 
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becomes distinguished as a sub-population of the MM. The CM cells condense 
around the ureteric tip to form cap-like clusters 3. Nephron formation will later be 
induced in a subset of  the CM cells by Wnt9b emanating from the epithelium of the 
ureteric tips 33. In response to this signal the induced CM cells give rise to a renal 
vesicle, the epithelial precursor structure of the nephron via MET. To maintain the 
CM as a nephron precursor pool until the termination of nephron induction, it 
establishes a balance between proliferation and differentiation 33.  
At E11.5, MM markers, like Eya1, Six1, Six2, Pax2 and Gdnf are still expressed 
throughout the metanephric blastema. After this stage expression of most of these  
factors will be maintained only in the CM clusters 32,34–36. Only Six1 is downregulated 
after E11.5 37. Two other mesenchymal precursor populations become detectable in 
the metanephrogenic field at E11.5. One of them is the renal stroma lineage, which is 
marked by expression of Foxd1. Spindle-shaped, Foxd1+ stroma precursors cover 
the surface of the first CM clusters at E11.5 38,39. The origin of the stroma population 
is still under investigation. Traditionally these cells are described as the outer part of 
the MM, which is not reached by inductive signals from the UB epithelium and 
therefore does not condense around it 40. Also the tailbud mesenchyme 41 and the 
neural crest 42 are discussed as possible sources for renal stroma cells. During 
embryonic development the fetal stroma cells will establish a kind of fibrocyte 
framework, embedding all epithelial structures of the kidney.  Their developmental 
function in the kidney is still under investigation. The third mesenchymal population of 
the metanephrogenic field at E11.5 expresses neither MM nor stroma markers. It is a 
stripe-shaped population of cells, which stretches along the UGR, between the MM 
and the mesenchymal coat of the ND. The population is marked by expression of the 
T-box transcription factor Tbx18, as Airik and colleagues found out in a previous 
expression analysis 43. At E11.5 the epithelium of the distal ureteric bud is embedded 
in this Tbx18+ mesenchyme. 
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Fig. 3: Early kidney and ureter development within the UGR  
CM, cap mesenchyme; IM, intermediate mesoderm; NM, nephrogenic mesenchyme; MM, metanephric 
mesenchyme; mes, mesonephric tubules; nd, nephric duct; ut, ureteric tip; pgc, progenitor germ cells. 
(The figure is based on informations from publications cited in the text) 
After the main mesenchymal and epithelial precursor tissues have been established 
and the ureteric bud has invaded the MM, further development of the kidney and 
ureter is regulated by signal exchange between these tissues. Patterning of the 
ureteric bud epithelium into a proximal segment, which establishes the renal 
collecting duct system and a distal segment, which gives rise to the ureter stalk, is 
regulated by the surrounding mesenchyme 44–46. The part of the UB which has 
invaded the MM undergoes several rounds of dichotomous branching in response to 
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GDNF-RET signaling, which is maintained between the CM-clusters and the UB-tip 
epithelium. This repetitive branching generates the collecting duct system of the 
kidney. The ureter stalk, the part of the ureteric bud which remains outside the 
kidney, shows mainly longitudinal growth. It will give rise to the ureter, which finally 
establishes the direct connection between kidney and bladder. During further 
development the ureter establishes a more elaborate tissue architecture. While the 
cells of the mesenchyme, which surrounds the newly formed ureter, are 
homogenously distributed at E11.5, the density of the mesenchyme increases close 
to the ureteric epithelium at E12.5 and the cells aquire a more cuboidal morphology 1. 
Expression of Tbx18 is maintained after E11.5 specifically in the undifferentiated 
ureteric mesenchyme (Fig. 4A). At E12.5, Tbx18 is expressed throughout the 
mesenchymal coat of the ureteric epithelium. Between E13.5 and E14.5 the ureteric 
epithelium starts to differentiate to establish the multilayered urothelium, consisting of 
an apical layer of so called superficial facet cells, followed by a layer of intermediate 
cells and by the basal cell layer 47. This architecture is established until E16.5, when 
the kidney begins to produce urine. Simultaneously, at E14.5, the subdivision of the 
surrounding mesenchyme into an inner condensed and an outer more loosely 
organized layer becomes even more obvious. At this stage expression of Tbx18 is 
restricted to the tightly packed mesenchyme close to the ureteric epithelium. Between 
E14.5 and E15.5 smooth muscle differentiation is initiated in the inner layers of the 
ureteric mesenchyme along the ureter in a proximal to distal direction. After E16.5, 
when the basic architecture of the ureter has been established, the four-layered 
organization of the ureter wall is recognizable. The urothelium is surrounded by a 
layer of fibrous connective tissue, the so-called lamina propria. This layer is followed 
by a thick coat of smooth muscle cells. The outermost layer of the wall consists of the 
loosely organized fibrocytes of the lamina adventitia, which attaches the ureter to the 
dorsal body wall 1.The structure of the mature ureter wall at E18.5 is shown in (Fig. 
4B). With the onset of smooth muscle differentiation Tbx18 is downregulated in the 
ureteric mesenchyme. At E16.5, its expression is restricted to the layer of smooth 
muscle cells. At E18.5, it is undetectable in the ureter wall. The development of the 
different specialized tissue layers of the ureter wall depends on signals from the 
ureteric epithelium 9,43, but little is known about the molecular regulation of this 
process. Shh, a member of the Hedgehog family of signaling molecules, is expressed 
in the UE throughout ureter development, while its receptor patched homolog 1 
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(Ptch1) is expressed in the adjacent UM 48. Shh loss-of-function mutants develop a 
hydroureter and hydronephrosis phenotype, characterized by a strongly dilated 
ureter. The ureter wall of these mutants lacks a functional smooth muscle layer and 
the kidney shows a destruction of the renal parenchyme due to increased hydrostatic 
pressure. It has been shown that Shh-signaling, which is partly mediated by 
mesenchymal bone morphogenetic protein 4 (Bmp4), is required for normal 
proliferation and regulation of smooth muscle differentiation in the ureter. Depending 
on the activated downstream pathways Shh seems to be involved in promotion as 
well as inhibition of smooth muscle differentiation. In the future it will be a challenge 
to analyze the mediators of Shh-signaling and to identify more pathways involved in 
ureter development. Canonical Wnt signaling, which is indispensable for normal 
kidney development 33, might also be of importance as a signal between the 
epithelium of the ureter stalk and the UM.  
 
6.3. Tbx18 and its function in ureter development 
Tbx18 is a vertebrate-specific member of the family of T-box transcription factors 
49,50. Its expression pattern during ureter development suggested that Tbx18 is 
involved in the regulation of ureteric smooth muscle development. As the work of 
Airik and colleagues revealed, it is in fact indispensable for the development of the 
ureteric smooth muscle coat 43. The characteristic feature of all T-box factors, the T-
box, is a DNA-binding domain, recognizing conserved DNA-motifs, the T-half sites, in 
the regulatory sequence of target genes 51. Subsequently, T-box factors influence the 
transcription of these genes, in a repressing or activating way. Their mode of 
regulation depends on the kind of co-factors recruited by them 52. The specificity of 
target gene regulation is generated by the distribution of T- half sites in the genome, 
as different T-box factors prefer a different number, spacing and orientation of these 
binding sites. Competition between activating and repressing T-box factors for the 
same DNA binding sites 49 and binding of T-box factors as hetero- or homodimers 
49,53–55 further increases the specificity of target gene regulation.  
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Fig. 4: Expression of Tbx18 during ureter development and structure of the mature ureter wall 
at E18.5 A: Tbx18 in situ hybridization expression analysis in the developing kidney and ureter at 
E11.5 (a), E12.5 (c), E14.5 (f), E16.5 (i), and E18.5 (l), in whole urogenital systems at E12.5 (b) and 
E14.5 (e), on transverse sections of ureters at E12.5 (d), E14.5 (h), and E16.5 (k), and on longitudinal 
sections of kidneys with attached ureters of wild-type embryos at E14.5 (g) and E16.5 (j). b, bladder; 
g, gonad; k, kidney; MM, metanephric mesenchyme; nd, nephric duct; p, pelvis; u, ureter; ue, ureteric 
epithelium; um, ureteric mesenchyme; uti, ureter tip; us, ureter stalk. Scale bars: 200 μm (a–c, e–g, i, 
j, and l), 100 μm (d, h, and k). Figure and figure legend adopted with minor modifications from: “Tbx18 
Regulates the Development of the Ureteral Mesenchyme.” Airik, Rannar et al. 2006. Permission given 
by Journal of Clinical Investigation B: Four-layered structure of the ureter wall at E18.5. 
For the Tbx18 protein, interaction with T-box factors and with other transcription 
factors has been shown in vitro. The significance of the interaction with Six1 during 
smooth muscle development was also shown in vivo with the analysis of double 
heterozygous and homozygous mutants. 56, 57. Interaction of Tbx18 with Groucho co-
repressors was shown to contribute significantly to the transcription repressing 
function of Tbx18, which has also been identified in in vitro experiments 49. To 
understand the function of a transcription factor it is necessary to identify direct target 
genes. In the case of Tbx18, a loss-of-function as well as conditional misexpression 
mouse mutants were generated and analyzed for this purpose. Newborn Tbx18 loss-
of-function  pups die shortly after birth, showing malformations of the rib cage and 
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severe difficulties in taking breath 58. During embryonic development other defects 
were found in the development of the inner ear 59, the heart 60 and the UGS 43 of the 
mutant. In most cases the analysis of the Tbx18 loss-of-function and gain-of-function 
phenotype, which was studied during somite development, did not lead to the 
identification of the molecular mechanisms regulated by Tbx18. The maintenance of 
the boundary between precursor populations was identified as a common potential 
function of Tbx18 in different embryonic organ primordia. Also a function in the 
specification or differentiation of mesenchymal precursors, in the de novo 
establishment of precursor populations or in the regulation of basic processes like 
adhesion, migration, proliferation or survival were considered 43,50,58,59,61. Results of in 
vitro analyses and in vivo experiments in guinea pigs indicated that Tbx18 was 
sufficient to convert working myocardium into pacemaker-like cells 62,63. These 
findings could be confirmed only partly in the analysis of mice which showed 
misexpression of Tbx18 throughout the myocardium. This misexpression resulted in 
deregulation of a number of genes but in most cases the deregulation was identified 
as secondary to functional defects of the hearts. Only Gja5, a gap junction protein 
seemed to be directly regulated under these conditions. Activation of the pacemaker 
expression program was not observed 64. Up to now, direct target genes of Tbx18 
could not be identified under physiological conditions due to the lack of a specific 
Tbx18 antibody, which might be used for Chromatin-immunoprecipitation 
experiments followed by sequencing of the precipitated DNA bound by Tbx18. 
The analysis of the Tbx18-loss-of-function phenotype in the urogenital system 
revealed severe defects in ureter and kidney development. Until E18.5 Tbx18-loss of 
function mutants developed hydroureters and severe hydronephrosis, a strong 
dilatation of the ureter and renal pelvis accompanied by the destruction of the renal 
parenchyme. This phenotype is commonly caused by strongly increased hydrostatic 
pressure after the accumulation of urine, which cannot be transported to the bladder 
or released into the bladder lumen due to physical or functional obstruction of the 
ureter 65. In the case of the Tbx18-mutant, urine transport was apparently impaired 
due to a complete loss of the ureteric smooth muscle layer, resulting in a functional 
obstruction. The kidneys of the mutant showed a ventral rotation of about 90°, which 
positioned the opening of the pelvis on the ventral side. The ureter was severely 
shortened and the gonads were attached to the caudal apex of the kidney by ectopic 
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ligamentous tissue. First changes in the histology of the ureter wall were found at 
E12.5, when the mutant UM failed to establish an inner ring of tightly packed 
mesenchymal cells around the ureteric epithelium. The normal three layered 
organization of the UM around the UE was never established in the mutant. With the 
onset of urine production at E16.5, the mutant ureter started to dilate and the thin 
layer of mesenchyme lacked expression of smooth muscle differentiation markers. 
Most likely secondary to the mesenchymal defects also the urothelium did not show 
expression of differentiation markers. In a short term lineage tracing using a 
Tbx18LacZ-allele, to mark Tbx18-derived cells temporarily, Tbx18-derived cells were 
found only along the developing ureter. In Tbx18-mutant embryos, in contrast, Tbx18-
derived cells spread over the kidney surface, contributing to ligaments which tethered 
the gonads to the kidney. Proliferation was significantly reduced in both the UM and 
UE at late developmental stages. Expression of Uncx4.1, Wt1, Raldh2 and Foxd1, 
markers for the CM and renal stroma respectively, was unchanged at E12.5 whereas 
Ptch1 and Bmp4 were downregulated and Secreted frizzled related protein 2 (Sfrp2) 
was undetectable in the mutant UM. The molecular process regulated by Tbx18 
during ureteric smooth muscle development remained unclear. A role in the 
aggregation of the UM along the UE or in the perception of epithelium derived signals 
by the mesenchyme was suggested. The very early expression of Tbx18 and early 
onset of developmental defects pointed towards a function in the specification of the 
UM. Due to the downregulation of Tbx18 with the onset of smooth muscle 
differentiation also a function in maintaining the UM in an undifferentiated state was 
considered. To identify the biological process regulated by Tbx18 during ureter 
development and to find target genes mediating the function of Tbx18 in this process, 
further analysis was necessary. A first analysis of the effect of temporal and spatial 
misexpression of Tbx18 was done during my master thesis. This analysis revealed 
the necessity of a tight regulation of Tbx18-expression in the UGS progenitor tissues, 
to allow normal kidney and ureter development. 
6.4. The aim of this thesis 
The aim of this thesis is to further analyze the function of Tbx18 in ureter 
development and to investigate pathways regulating Tbx18 expression or mediating 
its function. This shall be done in three different projects:  
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The first project aims at a more detailed characterization of the Tbx18 expressing 
precursor population in the UGR and its contribution to the developing organs of the 
UGS. In a short term lineage tracing of the Tbx18-derived cells published previously 
by Airik and colleagues, labeling could be achieved only for a limited period of time 
by LacZ expression 43. To overcome this problem, a Tbx18cre-line in combination with 
a Rosa26mTmG-reporter will be used to permanently label all Tbx18-derived cells by 
GFP expression for a fate mapping in wildtype and Tbx18-loss-of-function UGS.  
In the second project the effects of conditional misexpression of Tbx18 will be 
analyzed in vivo in three different mouse models. A phenotypic analysis of these 
mice will be performed with the aim to identify biological processes, expression 
programs and finally single genes, which can be regulated by Tbx18. These 
candidate genes shall than be evaluated for their physiological relevance in the 
Tbx18-loss of function mutant. 
Misexpression experiment 1: During ureter development Tbx18 expression is 
progressively restricted to the inner ring of the UM. In the first mouse mutant, the 
expression of Tbx18 is maintained in all cells derived from the early stripe-like 
expression domain in the metanephrogenic field. The analysis of this mutant shall 
answer the question, if restriction of Tbx18 is essential for UM patterning and 
differentiation or for renal stroma development.  
Misexpression experiment 2: In the second misexpression mutant, Tbx18 expression 
is expanded from the UM-precursor domain to the complete metanephrogenic field 
and all its derivatives. This experiment is supposed to answer the question, if Tbx18 
has the potential to change the specification of the early mesenchymal compartments 
in this precursor field.  
Misexpression experiment 3: A Tbx18VP16 fusion protein that activates transcription 
shall be expressed in all Tbx18-derived cells. The analysis of this mutant is supposed 
to provide first evidence for a transcription activating or repressing function of Tbx18 
in vivo. 
In the third project of this thesis the significance of canonical Wnt-signaling for the 
development of the ureteric smooth muscle layer and its connection to Tbx18 shall be 
analyzed in vivo. For this purpose the phenotype of two conditional mutants, which 
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show over-activation or a loss of canonical Wnt-signaling in the Tbx18-derived 
ureteric mesenchyme respectively, will be examined.
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11. Conclusions 
The aim of this thesis was to investigate the function of Tbx18 during ureteric smooth 
muscle development and to analyze its connection to other pathways involved in this 
process. The results of this study revealed the early establishment of a multipotent 
Tbx18+ progenitor lineage, which contributes to most organs of the UGS, while only 
ureteric smooth muscle development depends on the function of Tbx18.  
The analysis of Tbx18-gain- and loss-of-function mutants showed, that Tbx18 is not 
only necessary for smooth muscle development but also sufficient to expand it into 
neighboring tissue layers, most likely in cooperation with epithelium derived signals, 
like Wnt-signaling.  
Analysis of mutants expressing the artificial, transcription activating Tbx18VP16-allele 
gave first in vivo indications for the requirement of Tbx18 as a repressor during 
smooth muscle development. 
Finally we were able to show, that the early missexpression of Tbx18 is insufficient to 
expand the UM precursor population, while the early analysis of the Tbx18-loss-of-
function mutant showed that Tbx18 is necessary to repress the early metanephric 
expression program in the UM precursor population to allow ureteric smooth muscle 
development. 
Tbx18 marks a new multipotent progenitor population of the metanephrogenic 
field 
We were able to show that the Tbx18+ lineage is established along the urogenital 
ridge between E9.5 and E10.5 as a mesenchymal sub-population which never 
showed an overlap with nephrogenic tissue of the ridge. Also this lineage is distinct 
from the renal stroma precursors from E11.5 on. The segregation of cells contributing 
either to the UM or the renal stroma at E11.5 was visualized for the first time in our 
publication by DiI-labeling of single cell clusters in metanephric explant at E11.5 
cultures. It revealed that the cells of the Tbx18+ UM-precursor population in young 
E11.5 embryos can actually be assigned to three different fractions depending on 
their distance from the ureteric epithelium at this stage. The most cranial part of the 
population will be removed by apoptosis. The cells which are located 200 µm or less 
far away from the ureteric epithelium contribute to the stroma of the kidney and only a 
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small fraction close to the epithelium, which could not be distinctly labeled, remains 
part of the UM coat. It would be interesting to find out how long the invasion of the 
renal interstitium continues after E11.5 when Tbx18 expression is restricted to the 
UM coat. It is possible, that the proliferating population of UM cells continues to 
contribute to the renal stroma. The lineage tracing of permanently labeled Tbx18-
derived cells showed that cells from the two expression domains of Tbx18 in the 
UGR, the cranial UGR mesenchyme and its surface epithelium as well as the 
population in the metanephrogenic field contribute to most organs of the UGS. The 
complementary fate mapping in the loss of function mutant revealed that its function 
is restricted to the control of ureteric smooth muscle development. Permanent 
labeling of the Tbx18-derived cell population in the Tbx18-loss of function mutant and 
heterozygous controls allowed a comparable in vivo and ex vivo lineage tracing and 
the quantification of Tbx18-derived cells in different zones of the renal stroma. It 
showed the increased contribution of Tbx18-mutant cells to the renal stroma, which 
lead us to the conclusion that these cells adopt a stroma-like default fate. 
Tbx18 and ureteric smooth muscle development 
The analysis of the Tbx18cre/+;HprtTbx18-mutant revealed that maintained expression 
of Tbx18 throughout the coat of ureteric mesenchyme is sufficient to expand ureteric 
smooth muscle development into the innermost layer of mesenchyme which normally 
differentiates into the ACTA2- fibrocytes of the lamina propria. The absence of 
ectopic smooth muscle differentiation in the outermost layer of Tbx18 misexpressing 
ureteric mesenchyme indicates that smooth muscle development still depends on the 
presence of additional factors, which are restricted to the inner layers of the 
mesenchymal coat. The analysis of the conditional β-catenin-loss of function mutant 
and the examination of Wnt signaling pathway in the Tbx18-loss of function mutant, 
which are part of the publications in this thesis, indicate that expression of Tbx18 
after E11.5 and Wnt-signaling between the UE and UM depend on each other. The 
conditional β-catenin-loss of function mutant showed a loss of Tbx18 expression and 
an expansion of lamina propria fibroblast markers into the inner layers of UM, while 
no ureteric smooth muscle layer was detectable. Re-expression of Tbx18 in the 
conditional β-catenin-loss of function background, in Tbx18cre/+;HprtTbx18/y;Ctnn1fl/fl-
mutants did not rescue the loss of ureteric smooth muscle tissue. This indicates that 
the function of Tbx18 in ureteric smooth muscle development depends on functional 
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canonical Wnt-signaling. Thus UE-derived Wnt might be the factor which limits the 
diameter of the ureteric smooth muscle layer in the Tbx18cre/+; HprtTbx18/y-mutant. The 
results of the different publications in this thesis indicate that Tbx18-expression and 
functional canonical Wnt-signaling depend on each other in this context. 
Furthermore, canonical Wnt signals and Tbx18 seem to be needed in combination to 
allow ureteric smooth muscle development. It would be interesting to find out if 
expression of Tbx18 in the UM and the presence of Wnt-proteins, which can activate 
the canonical signaling pathway, are also sufficient to activate smooth muscle 
development. It has been shown that forced activation of canonical Wnt-signaling in 
the UM can activate smooth muscle differentiation and that in this case, the process 
does not depend on Tbx18 66. To find out, if Tbx18 can expand the radius of the UM 
which reacts to Wnt signals, one could use an organ culture of E14.5 
Tbx18cre/+;HprtTbx18/y ureter primordia and add Wnt-coated beads to the outer surface 
of the ureter. If the combination is sufficient, to activate smooth muscle differentiation 
ectopically, we would expect smooth muscle differentiation in the outer UM, which 
normally differentiates into the tunica adventitia layer.  
Taken together, these results are well compatible with a function of Tbx18 in making 
the ureteric mesenchyme responsive to epithelium derived signals to allow ureteric 
smooth muscle development, which was initially proposed after the analysis of the 
Tbx18-loss of function phenotype by Airik and colleagues. 
New in vivo indications for a repressing function of Tbx18 in ureteric smooth 
muscle development 
The examination of embryos, which showed expression of Tbx18VP16 in all Tbx18-
derived cells, revealed a cell-autonomous loss of smooth muscle differentiation in the 
affected cells. The strongly affected individuals, among the heterozygous female 
misexpression mutants, showed several features of the Tbx18-loss of function 
phenotype, like the very characteristic ventral rotation of the kidney, the shortened 
ureter and the loss of the ureteric smooth muscle layer. These results brought the 
first indication for a transcription repressing function of Tbx18 in this context. The 
massive loss of Tbx18-derived cells in the Tbx18VP16 expressing embryos might 
occur due to the fact that in this mutant, target genes which should be repressed are 
now strongly activated. Of course also off-target effects might be involved. If it will be 
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possible in the future to sort out false targets from true ones, this mutant might be a 
valuable tool for the identification of target genes which can be regulated by Tbx18 in 
an in vivo setting. This sorting might be done by overlaying the results of microarrays 
of Tbx18-loss and gain of function and Tbx18VP16 expressing mutants compared to 
wildtypes.  
Tbx18 and the specification of the ureteric mesenchyme 
One of our initial questions was, if Tbx18 has an early function in the specification of 
the ureteric mesenchyme as the precursor population of the ureteric smooth muscle 
tissue. Our analysis of Pax3-cre/+;HprtTbx18/y misexpression mutants showed that 
Tbx18 is not sufficient to expand the UM-precursor population within the UGR, as 
there was no expansion of early markers of this compartment detectable. The 
analysis also revealed that Tbx18 is sufficient to suppress the development of 
nephrogenic mesenchyme in the ridge. We investigated the physiological relevance 
of the NM-repressing potential of Tbx18 and found that Tbx18 is also necessary to 
repress the early MM-expression program in the UM-progenitor population at this 
stage. We excluded the possibility of an expansion of MM marker expression due to 
boundary maintenance defects by immunohistochemical detection of GFP(Tbx18) 
and Eya1 in the metanephrogenic field at E11.5 in Tbx18GFP/+ heterozygous controls 
and Tbx18GFP/GFP-loss of function mutants. This examination showed Eya1/GFP-
double positive cells in the UM-domain, arguing for a change to the molecular 
character of the UM. Altered expression of mesenchymal Eya1 and Gdnf was 
accompanied by secondary changes in the ureteric epithelium and we were able to 
show that first morphological changes in the loss of function mutant occurred 
concomitantly with the altered mesenchymal and epithelial marker expression. We 
wondered how far the ureteric mesenchyme was changed towards a metanephric 
character after a loss of Tbx18. The fate mapping of Tbx18-derived cells in the 
mutant partly answered this question. In this fate mapping we found no contribution 
of Tbx18-derived cells to the cap mesenchyme or the nephrons in either Tbx18-
mutant or control embryos. Obviously the UM did not adopt a full CM-like character. 
The fact that Eya1 expression is expanded only transiently and is basically restricted 
to the mesenchyme close to the ureteric epithelium implies that the function of Tbx18 
lies in the regulation of the mesenchymal response to epithelium derived signals. By 
repressing the activation of Eya1 and, most likely secondary, of Gdnf Tbx18 might 
Conclusions  
 
131 
 
specify the UM as a distinct mesenchymal precursor population indirectly. The 
analysis of the two Eya1-misexpression mutants, which was done to determine the 
significance of ectopic Eya1 expression for the development of the Tbx18-loss of 
function phenotype, brought conflicting results. Misexpression of Eya1 throughout the 
metanephrogenic field led to the expansion of Gdnf and Six1 expression in the 
mesenchyme and to expanded expression of Ret in the UE. These molecular 
changes were accompanied by alterations in ureteric branching. These results 
indicate that ectopic Eya1 might be responsible for the early defects in the Tbx18-
loss of function mutant. The ectopic expression of Eya1 in the UM in contrast, 
showed only minor effect on ureter development. Overall ectopic Eya1 expression 
and activation of other MM markers might rather be a symptom of the defective 
mechanism in the Tbx18-loss of function mutant than the causative agent. We did not 
address the question about a direct regulation of Eya1 by Tbx18 on the level of 
chromatin immunoprecipitation in this analysis. This analysis might be interesting in 
the future, as soon as a suitable antibody is available. Even if Eya1 is not the main 
mediator of the Tbx18-loss of function phenotype, its expression might still be 
regulated by Tbx18. It would be a great progress to identify a gene which is regulated 
by Tbx18 under physiological conditions. 
There is an accumulating amount of evidence for a function of Tbx18 in regulating 
the perception of or reaction to epithelial signals in the UM. Hence a promising 
approach for future identification of direct target genes of Tbx18 might be to analyze 
the overlap between transcriptional changes in the Tbx18-loss of function mutant and 
mutants for the pathway which are active between the epithelium and the 
mesenchyme. Transcription analysis might be done by microarrays. This would mean 
to approach the question on a large and unbiased scale.  
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